RBC Capital Maintains Hold Rating on Accelerant Holdings
RBC Capital analyst Rowland Mayor has maintained a hold rating on Accelerant Holdings (ARX) with a price target of $20.25.
Stocks · News reference
Accelerant has scheduled the release of its financial results for the third quarter of 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
RBC Capital analyst Rowland Mayor has maintained a hold rating on Accelerant Holdings (ARX) with a price target of $20.25.
Altea, a healthcare-focused insurance business backed by Accelerant subsidiary Mission Underwriters, has announced its expansion into the U.S. market, utilizing Accelerant's Risk Exchange platform for insurance capacity.
Analysts downgraded SoundThinking, Moderna, Accelerant, Mobileye and Dow, revising their ratings and price targets.
Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.
Analysts downgraded Accelerant, Autoliv, Compass Therapeutics, Wave Life Sciences and PG&E; price targets for CMPX and PCG were cut.